78 related articles for article (PubMed ID: 24074379)
1. The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes.
Cohen Y; Gutwein O; Garach-Jehoshua O; Bar-Haim A; Kornberg A
Hematology; 2014 Jul; 19(5):286-92. PubMed ID: 24074379
[TBL] [Abstract][Full Text] [Related]
2. Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells.
Hatfield KJ; Reikvam H; Bruserud Ø
Expert Opin Ther Targets; 2014 Nov; 18(11):1237-51. PubMed ID: 25200484
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
Klein B; Seckinger A; Moehler T; Hose D
Recent Results Cancer Res; 2011; 183():39-86. PubMed ID: 21509680
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
5. Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Fagerli UM; Ullrich K; Stühmer T; Holien T; Köchert K; Holt RU; Bruland O; Chatterjee M; Nogai H; Lenz G; Shaughnessy JD; Mathas S; Sundan A; Bargou RC; Dörken B; Børset M; Janz M
Oncogene; 2011 Jul; 30(28):3198-206. PubMed ID: 21478911
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and risk stratification in multiple myeloma.
van de Donk NW; Sonneveld P
Hematol Oncol Clin North Am; 2014 Oct; 28(5):791-813. PubMed ID: 25212883
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced apoptosis inhibitor 1 inhibits the growth and proliferation of multiple myeloma.
Wang X; Pan J; Li J
Mol Med Rep; 2015 Aug; 12(2):2056-62. PubMed ID: 25901506
[TBL] [Abstract][Full Text] [Related]
8. The hypoxia-mimetic agent cobalt chloride induces cell cycle arrest and alters gene expression in U266 multiple myeloma cells.
Bae S; Jeong HJ; Cha HJ; Kim K; Choi YM; An IS; Koh HJ; Lim DJ; Lee SJ; An S
Int J Mol Med; 2012 Nov; 30(5):1180-6. PubMed ID: 22941251
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
10. Insights from the gene expression profiling of multiple myeloma.
Claudio JO; Masih-Khan E; Stewart AK
Curr Hematol Rep; 2004 Jan; 3(1):67-73. PubMed ID: 14695854
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
Zhou Y; Gwadry FG; Reinhold WC; Miller LD; Smith LH; Scherf U; Liu ET; Kohn KW; Pommier Y; Weinstein JN
Cancer Res; 2002 Mar; 62(6):1688-95. PubMed ID: 11912141
[TBL] [Abstract][Full Text] [Related]
12. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of miRNA-15a/-16 expression on the drug resistance of myeloma cells].
Zang MR; Li F; An G; Xie ZQ; Li CH; Yu Z; Xu Y; Qiu LG; Hao M
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1100-3. PubMed ID: 22781767
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes.
Grcević D; Kusec R; Kovacić N; Lukić A; Lukić IK; Ivcević S; Nemet D; Seiwerth RS; Ostojić SK; Croucher PI; Marusić A
Leuk Res; 2010 Jun; 34(6):742-51. PubMed ID: 19926132
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.
Verdelli D; Nobili L; Todoerti K; Intini D; Cosenza M; Civallero M; Bertacchini J; Deliliers GL; Sacchi S; Lombardi L; Neri A
Hematol Oncol; 2009 Mar; 27(1):23-30. PubMed ID: 18759374
[TBL] [Abstract][Full Text] [Related]
16. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
17. TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability.
Pommier RM; Gout J; Vincent DF; Alcaraz LB; Chuvin N; Arfi V; Martel S; Kaniewski B; Devailly G; Fourel G; Bernard P; Moyret-Lalle C; Ansieau S; Puisieux A; Valcourt U; Sentis S; Bartholin L
Cancer Res; 2015 Oct; 75(20):4335-50. PubMed ID: 26282171
[TBL] [Abstract][Full Text] [Related]
18. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
[TBL] [Abstract][Full Text] [Related]
19. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.
Campo S; Allegra A; D'Ascola A; Alonci A; Scuruchi M; Russo S; Avenoso A; Gerace D; Campo GM; Musolino C
Br J Haematol; 2014 Jun; 165(6):801-13. PubMed ID: 24620752
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow neoplastic niche in leukemia.
Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]